Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Journal of Cardiovascular Pharmacology|August 11, 2023
Cardiovascular Risk Management in Patients Treated With Janus Kinase InhibitorsJill T Shah, Keya T Shah, Alisa N Femia, et al.
Echocardiography (Mount Kisco, N.Y.)|October 14, 2018
Average e' velocity on transthoracic echocardiogram is a novel predictor of left atrial appendage sludge or thrombus in patients with atrial fibrillationMichael S Garshick, Jennifer Mulliken, Matthew Schoenfeld, et al.
American Heart Journal|January 10, 2024
Burden of cardiometabolic risk factors and vascular healthCarine E Hamo, Florencia Schlamp, Kamelia Drenkova, et al.
Scientific Reports|April 27, 2021
Reshaping of the gastrointestinal microbiome alters atherosclerotic plaque inflammation resolution in miceMichael S Garshick, Cyrus Nikain, Michael Tawil, et al.
JCI Insight|December 22, 2025
A platelet transcriptomic signature of thromboinflammation predicts cardiovascular riskAntonia Beitzen-Heineke, Matthew A Muller, Yuhe Xia, et al.
JACC. Advances|August 16, 2025
IL-1 Pathway Inhibition in Recurrent Pericarditis Management: Real-World Adoption of Corticosteroid Sparing in RESONANCEPaul C Cremer, Sushil A Luis, Michael S Garshick, et al.
Journal of the American Academy of Dermatology|December 1, 2020
CCL20 in psoriasis: A potential biomarker of disease severity, inflammation, and impaired vascular healthYoussef A Elnabawi, Michael S Garshick, Michael Tawil, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 16, 2023
An inflammatory transcriptomic signature in psoriasis associates with future cardiovascular eventsMichael S Garshick, Tessa J Barrett, MacIntosh G Cornwell, et al.
Pageof 5